2004
DOI: 10.1089/hum.2004.15.ft-2
|View full text |Cite
|
Sign up to set email alerts
|

Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
76
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(78 citation statements)
references
References 72 publications
1
76
1
Order By: Relevance
“…21 Moreover, a phase I clinical trial using PEGylated PLL/pDNA complexes has been conducted in cystic fibrosis (CF) patients with some success in partial correction of the CF chloride transport defect, while no inflammatory response or other toxicity due to the gene vector was observed. 33 Nevertheless, an ideal nonviral gene transfer agent has not been identified up to now. Gene delivery using P(DMAEMA)-based gene vectors is a complex process and PEGylation may largely affect their physiochemical and biological activity but these processes have not been addressed in detail as has previously investigated for PEI-based gene vectors.…”
Section: Introductionmentioning
confidence: 99%
“…21 Moreover, a phase I clinical trial using PEGylated PLL/pDNA complexes has been conducted in cystic fibrosis (CF) patients with some success in partial correction of the CF chloride transport defect, while no inflammatory response or other toxicity due to the gene vector was observed. 33 Nevertheless, an ideal nonviral gene transfer agent has not been identified up to now. Gene delivery using P(DMAEMA)-based gene vectors is a complex process and PEGylation may largely affect their physiochemical and biological activity but these processes have not been addressed in detail as has previously investigated for PEI-based gene vectors.…”
Section: Introductionmentioning
confidence: 99%
“…10 Attempts to improve the efficiency of nonviral vectors are being made, including the addition of peptide ligands to target the vector to receptors localized on the apical membrane of airway epithelial cells, 11 and the development of nanoparticles to improve nuclear entry. 12 Here we have assessed, if sonoporation, the use of high-frequency ultrasound (US) increases nonviral gene transfer to the lung.…”
Section: Introductionmentioning
confidence: 99%
“…[104] In fact, polyplexes are being investigated in phase I and phase II clinical trials for the treatment of cystic fibrosis and ocular degenerative diseases. [105] Hybrids of lipids with polymers have been explored to improve gene delivery. [106] In this system, DNA is pre-condensed with either poly-L-lysine, [107] protamine, [108] histone or several synthetic polypeptides, [109] followed by lipid wrapping using either cationic liposomes, anionic liposomes or amphiphilic polymers.…”
Section: Polymer-based Nonviral Vectorsmentioning
confidence: 99%